Cytokines and neopterin in antiphospholipid syndrome

Objective. To study clinical significance of proinflammatory cytokines (tumor necrosis factor α – TNFα, interleukine 6 – IL6, IL18), soluble receptors of TNFα (sTNF-R), anti- inflammatory cytokines (IL10) and integral marker of cytokine-dependent cell immune response activation neopterin in antiphos...

Full description

Saved in:
Bibliographic Details
Main Authors: E N Alexandrova, A A Novikov, T M Reshetnyak, T V Popkova, N G Klyukvina, M A Diatroptova, M V Cherkasova, L N Denisov, E L Nasonov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2009-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/591
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849688732116975616
author E N Alexandrova
A A Novikov
T M Reshetnyak
T V Popkova
N G Klyukvina
M A Diatroptova
M V Cherkasova
L N Denisov
E L Nasonov
author_facet E N Alexandrova
A A Novikov
T M Reshetnyak
T V Popkova
N G Klyukvina
M A Diatroptova
M V Cherkasova
L N Denisov
E L Nasonov
author_sort E N Alexandrova
collection DOAJ
description Objective. To study clinical significance of proinflammatory cytokines (tumor necrosis factor α – TNFα, interleukine 6 – IL6, IL18), soluble receptors of TNFα (sTNF-R), anti- inflammatory cytokines (IL10) and integral marker of cytokine-dependent cell immune response activation neopterin in antiphospholipid syndrome (APS).Material and methods. Serum concentration of cytokines and neopterin was evaluated by immunoenzyme assay with commercial kits “BioSource International, Inc.” (USA), “Bender MedSystems” (Austria) and “IBL” (Germany) in 39 pts with primary APS (PAPS), 53 pts with secondary APS (SAPS) associated with systemic lupus erythematosus (SLE), 164 pts with SLE and 54 healthy donors.Results. Level of Th1 cytokines (TNFα, IL18), sTNF-R and neopterin in PAPS, SAPS and SLE as well as Th2 cytokines (IL6, IL10) in SAPS and SLE were significantly higher than in donors (p<0,05). TNFα elevation in PAPS was associated with damage of cardiac valves (p<0,05) and CNS (p<0,01), IL18 elevation – with chronic leg ulcers (p<0,001). Most prominent sTNFα-R elevation in SAPS was revealed in pts with thrombocytopenia (p<0,05). Neopterin hyperproduction in APS was associated with cardiac valve damage16 (p<0,001). IL10 level elevation in APS correlated with decreased thrombosis history (r=- 0,4; p<0,02), in SLE with APS – with decrease of damage score SLICC (r=-0,7; p<0,001) what proves protective significance of IL10 in relation to thrombosis development and disease progression. Increased concentration of IL 18 was associated with atherogenic disturbances presented as hypertrigliceridemia (r=0,6; p<0,01) and decrease of HDLP cholesterol (r—0,4; p<0,01). Positive correlation between TNFα, IL6 and neopterin level, IgM anticardiolipine antibodies and IgG/IgM antiprothrombin antibodies (p<0,05) was revealed. Cytokine, sTNFα-R and neopterin level elevation in SLE with APS was associated with increase of SLEDAI and ECLAM activity indices (p<0,05). Conclusion. Cytokine and neopterin hyperproduction reflecting cell immunity activation and inflammation is an important factor of APS pathogenesis.
format Article
id doaj-art-bb99770c58dd4493a4194e68cbce7326
institution DOAJ
issn 1995-4484
1995-4492
language Russian
publishDate 2009-04-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj-art-bb99770c58dd4493a4194e68cbce73262025-08-20T03:21:51ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922009-04-01472101610.14412/1995-4484-2009-453531Cytokines and neopterin in antiphospholipid syndromeE N AlexandrovaA A NovikovT M ReshetnyakT V PopkovaN G KlyukvinaM A DiatroptovaM V CherkasovaL N DenisovE L NasonovObjective. To study clinical significance of proinflammatory cytokines (tumor necrosis factor α – TNFα, interleukine 6 – IL6, IL18), soluble receptors of TNFα (sTNF-R), anti- inflammatory cytokines (IL10) and integral marker of cytokine-dependent cell immune response activation neopterin in antiphospholipid syndrome (APS).Material and methods. Serum concentration of cytokines and neopterin was evaluated by immunoenzyme assay with commercial kits “BioSource International, Inc.” (USA), “Bender MedSystems” (Austria) and “IBL” (Germany) in 39 pts with primary APS (PAPS), 53 pts with secondary APS (SAPS) associated with systemic lupus erythematosus (SLE), 164 pts with SLE and 54 healthy donors.Results. Level of Th1 cytokines (TNFα, IL18), sTNF-R and neopterin in PAPS, SAPS and SLE as well as Th2 cytokines (IL6, IL10) in SAPS and SLE were significantly higher than in donors (p<0,05). TNFα elevation in PAPS was associated with damage of cardiac valves (p<0,05) and CNS (p<0,01), IL18 elevation – with chronic leg ulcers (p<0,001). Most prominent sTNFα-R elevation in SAPS was revealed in pts with thrombocytopenia (p<0,05). Neopterin hyperproduction in APS was associated with cardiac valve damage16 (p<0,001). IL10 level elevation in APS correlated with decreased thrombosis history (r=- 0,4; p<0,02), in SLE with APS – with decrease of damage score SLICC (r=-0,7; p<0,001) what proves protective significance of IL10 in relation to thrombosis development and disease progression. Increased concentration of IL 18 was associated with atherogenic disturbances presented as hypertrigliceridemia (r=0,6; p<0,01) and decrease of HDLP cholesterol (r—0,4; p<0,01). Positive correlation between TNFα, IL6 and neopterin level, IgM anticardiolipine antibodies and IgG/IgM antiprothrombin antibodies (p<0,05) was revealed. Cytokine, sTNFα-R and neopterin level elevation in SLE with APS was associated with increase of SLEDAI and ECLAM activity indices (p<0,05). Conclusion. Cytokine and neopterin hyperproduction reflecting cell immunity activation and inflammation is an important factor of APS pathogenesis.https://rsp.mediar-press.net/rsp/article/view/591antiphospholipid syndrometumor necrosis factor αsoluble tnfα receptorsil6il10il18neopterinantiphospholipid antibodiescell immune response activationinflammation
spellingShingle E N Alexandrova
A A Novikov
T M Reshetnyak
T V Popkova
N G Klyukvina
M A Diatroptova
M V Cherkasova
L N Denisov
E L Nasonov
Cytokines and neopterin in antiphospholipid syndrome
Научно-практическая ревматология
antiphospholipid syndrome
tumor necrosis factor α
soluble tnfα receptors
il6
il10
il18
neopterin
antiphospholipid antibodies
cell immune response activation
inflammation
title Cytokines and neopterin in antiphospholipid syndrome
title_full Cytokines and neopterin in antiphospholipid syndrome
title_fullStr Cytokines and neopterin in antiphospholipid syndrome
title_full_unstemmed Cytokines and neopterin in antiphospholipid syndrome
title_short Cytokines and neopterin in antiphospholipid syndrome
title_sort cytokines and neopterin in antiphospholipid syndrome
topic antiphospholipid syndrome
tumor necrosis factor α
soluble tnfα receptors
il6
il10
il18
neopterin
antiphospholipid antibodies
cell immune response activation
inflammation
url https://rsp.mediar-press.net/rsp/article/view/591
work_keys_str_mv AT enalexandrova cytokinesandneopterininantiphospholipidsyndrome
AT aanovikov cytokinesandneopterininantiphospholipidsyndrome
AT tmreshetnyak cytokinesandneopterininantiphospholipidsyndrome
AT tvpopkova cytokinesandneopterininantiphospholipidsyndrome
AT ngklyukvina cytokinesandneopterininantiphospholipidsyndrome
AT madiatroptova cytokinesandneopterininantiphospholipidsyndrome
AT mvcherkasova cytokinesandneopterininantiphospholipidsyndrome
AT lndenisov cytokinesandneopterininantiphospholipidsyndrome
AT elnasonov cytokinesandneopterininantiphospholipidsyndrome